Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota.

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Abstract Text:

BACKGROUND AND OBJECTIVE: The objective of this research was to determine the effects of the dietary supplement Echinacea purpurea on aerobic and anaerobic bacteria common to the human gastrointestinal (GI) tract. Botanical extracts have shown in vitro antimicrobial effects against certain pathogenic bacteria. It is uncertain if medicinal herbs have any effect against pathogenic bacteria or on the native GI microbiota. METHODS: Fifteen human subjects consumed 1000 mg of standardized E. purpurea for 10 days. Faecal samples were collected at baseline, 10 days and 17-18 days following supplementation. Samples were tested for select aerobic and anaerobic bacteria using plate culture microbiological methods. RESULTS AND DISCUSSION: Significant increases were found for total aerobic bacteria, Bacteroides group and Bacteroides fragilis after E. purpurea exposure. Supplementation did not significantly alter the number of enteric bacteria, enterococci, lactobacilli, bifidobacteria or total anaerobic bacteria. CONCLUSION: Echinacea supplementation has altered the GI microbiota. The health consequences associated with this change are unknown but previous research has shown increased Bacteroides concentrations associated with diarrhoea, inflammatory bowel disease and increased risk of colon cancer. Additional research should delineate the role of Echinacea in the stimulation of Bacteroides and describe the effects of other botanical supplements to the GI microbiota.

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Publishing Authors By Initials

For similar male research abstracts see: male research

PUBMED ID PMID:

MEDLINE DATE:

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical pharmacy and therapeutics

VOLUME: 31

Page Numbers: 599-604

Journal Abbreviation: J Clin Pharm Ther

ISSN: 0269-4727

DAY: 28

MONTH: Dec

YEAR: 2006

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8704308

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Keywords Mesh Terms:

KEYWORDS: Male

MESH TERMS: microbiology

Chemical & Substance for Abstract: Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota.

AFFILIATION: Food Science and Human Environmental Sciences, Department of Human Environmental Sciences, University of Arkansas, Fayetteville, AR 72701, USA. llhill@uark.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Pharm Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota Related Publications

• ATP site-directed kinase inhibitors.
• An overview of the role of diet during the ageing process.
• Big and tall parents do not have more sons.
• Changes in cerebral hemodynamics in preterm infants with and without patent ductus arteriosus.
• Construction of YAC libraries with large inserts.
• Dysplasia epiphysialis punctata; report of a case and review of literature.
• Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota.
• Forum on research and scholarly activity.
• Gender And Age Related Changes In Strength And Submaximal Performance Outcomes For Individuals With CHF: 2240: Board #153 June 1 8:00 AM - 9:30 AM.
• Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.
• Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
• Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.
• Phosphoinositide-3-kinases (PI3Ks): Combined Comparative Modeling and 3D-QSAR To Rationalize the Inhibition of p110alpha.
• Placement and management of long-term central venous access catheters and ports.
• Quality assurance program for peripheral blood mononuclear cell cryopreservation.
• Queuing up for quality. Boosting quality with electronic work queues.
• Retroperitoneal hemorrhage after percutaneous nephrostomy.
• Safety and Effectiveness of Progressive Resistance TVaining in Heart Failure Patients: 2242: Board #155 June 1 8:00 AM - 9:30 AM.
• Salivary mucin as related to oral Streptococcus mutans in elderly people.
• Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
• The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• Use of the balloon on a guidewire as an adjunct to conventional angioplasty.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 1.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 2.